1157. Optimal Isolation Periods Based on Time Interval to Elimination of Scabies after Topical Agent in the Real Clinical Practice
Session: Poster Abstract Session: Healthcare Epidemiology: Environmental and Occupational Health
Friday, October 5, 2018
Room: S Poster Hall

Background: Scabies reemerged globally as the ninth of most highly prevalent skin diseases from 1990 to 2010. Existing topical agents, like permethrine and lindane are highly effective showing 95% or more therapeutic response. Patient isolation is only recommended for one day after treating with topical agents. However, there is little evidence-based recommendation on optimal isolation period after treatment in healthcare settings to prevent secondary infection.

Methods: All patients who were diagnosed from 2008 to 2017 with scabies at a referral university hospital in Seoul, Republic of Korea were analyzed. We investigated the time interval between symptom onset and diagnosis of scabies. The period from the application of topical agents and clinical resolution was also analyzed.

Results: A total of 23 patients were diagnosed with scabies. There was no crusted scabies such as Norwegian scabies. Seventy percent of these patients were referred from long-term care facilities. Median number of treatment was 3 times per patient (Interquartile range [IQR], 2-3). Time interval between the onset of symptoms and the diagnosis of scabies was median 4 days (IQR, 2-14). Median isolation period was 13 days (IQR, 8-15). Dermatologist confirmed successful treatment of 16 patients, the median time until confirmation was 15 days (IQR, 8-17). Three patients discontinued isolation before dermatologist's confirmation. After re-evaluation by a dermatologist, one of the three was re-isolated due to persistent scabies infestation.

Conclusion: Scabicides are highly efficacious, but repeated microscopic exam for confirming elimination is strongly recommended. Optimal isolation period should be individualized based on the repeated dermatologic examination.

Figure 1 A timeline of cured scabies patients confirmed by a dermatologist

Jebyung Park, MD1, Se Yoon Park, MD1, Jaijun Han, MD1, So Young Lee, BSN2, Gil Eun Kim, BSN2, Yeon Su Jeong, BSN2, Jin Hwa Kim, MSN2, Eunyoung Lee, MD1, Eun Jung Lee, MD1, Shi Nae Yu, MD3, Tark Kim, MD4, Min Hyok Jeon, MD3, Eun Ju Choo, MD4 and Tae Hyong Kim, MD, PhD1, (1)Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of (South), (2)Infection Control Team, Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of (South), (3)Division of Infectious Diseases, Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic of (South), (4)Division of Infectious Diseases, Soonchunhyang University Bucheon Hospital, Bucheon, Korea, Republic of (South)

Disclosures:

J. Park, None

S. Y. Park, None

J. Han, None

S. Y. Lee, None

G. E. Kim, None

Y. S. Jeong, None

J. H. Kim, None

E. Lee, None

E. J. Lee, None

S. N. Yu, None

T. Kim, None

M. H. Jeon, None

E. J. Choo, None

T. H. Kim, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.